Journal Title：Infectious Agents And Cancer

Infectious Agents and Cancer is an open access, peer-reviewed online journal that encompasses all aspects of basic, clinical, epidemiological and translational research providing an insight into the association between chronic infections and cancer.

The journal welcomes submissions in the pathogen-related cancer areas and other related topics, in particular:

• HPV and anogenital cancers, as well as head and neck cancers;

• EBV and Burkitt lymphoma;

• HCV/HBV and hepatocellular carcinoma as well as lymphoproliferative diseases;

• HHV8 and Kaposi sarcoma;

• HTLV and leukemia;

• Cancers in Low- and Middle-income countries.

The link between infection and cancer has become well established over the past 50 years, and infection-associated cancer contribute up to 16% of cancers in developed countries and 33% in less developed countries.

Preventive vaccines have been developed for only two cancer-causing viruses, highlighting both the opportunity to prevent infection-associated cancers by vaccination and the gaps that remain before vaccines can be developed for other cancer-causing agents. These gaps are due to incomplete understanding of the basic biology, natural history, epidemiology of many of the pathogens that cause cancer, the mechanisms they exploit to cause cancer, and how to interrupt progression to cancer in human populations. Early diagnosis or identification of lesions at high risk of progression represent the current most critical research area of the field supported by recent advances in genomics and proteomics technologies.

Infectious Agents and Cancer 是一本开放获取、同行评议的在线期刊，涵盖基础、临床、流行病学和转化研究的各个方面，深入了解慢性感染与癌症之间的关系。

该期刊欢迎在病原体相关癌症领域和其他相关主题投稿，特别是：

• HPV 和肛门生殖器癌，以及头颈癌；

• EBV 和伯基特淋巴瘤；

• HCV/HBV 和肝细胞癌以及淋巴组织增生性疾病；

• HHV8 和卡波西肉瘤；

• HTLV 和白血病；

• 低收入和中等收入国家的癌症。

在过去的 50 年里，感染与癌症之间的联系已经确立，在发达国家，感染相关癌症占癌症的 16%，在欠发达国家占 33%。

仅针对两种致癌病毒开发了预防性疫苗，这凸显了通过疫苗接种预防与感染相关的癌症的机会以及在开发用于其他致癌剂的疫苗之前仍然存在的差距。这些差距是由于对许多引起癌症的病原体的基本生物学、自然史、流行病学、它们用于引起癌症的机制以及如何中断人群中癌症进展的不完全理解。在基因组学和蛋白质组学技术的最新进展支持下，早期诊断或识别具有高进展风险的病变是该领域当前最关键的研究领域。